DCTPP1 blocking peptide product blog
Tags: Blocking Peptide; DCTPP1; XTP3TPA; DCTPP1 blocking peptide;
The DCTPP1 dctpp1 (Catalog #MBS9224856) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The DCTPP1 dctpp1 product has the following accession number(s) (GI #74733624) (NCBI Accession #Q9H773.1) (Uniprot Accession #Q9H773). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Hydrolyzes deoxynucleoside triphosphates (dNTPs) to the corresponding nucleoside monophosphates. Has a strong preference for modified dCTP. Activity is highest with 5-iodo-dCTP, followed by 5-bromo-dCTP, unmodified dCTP, 5-methyl-dCTP and 5-chloro-dCTP. Hydrolyzes 2-chloro-dATP and 2-hydroxy-dATP with lower efficiency, and has even lower activity with unmodified dATP, dTTP and dUTP (in vitro). Does not hydrolyze ATP, UTP, ITP, GTP, dADP, dCDP or dGTP. May protect DNA or RNA against the incorporation of non- canonical nucleotide triphosphates. May protect cells against inappropriate methylation of CpG islands by DNA methyltransferases (By similarity).
Cellular Location: Cytoplasm. Neoplasm Metastasis are some of the diseases may be linked to XTP3TPA Antibody (N-term) Blocking Peptide. The following patways have been known to be associated with this gene. Esophagus, Kidney, Liver, Lung, Lymph, Lymph Node, Stomach tissues are correlated with this protein.